Researchers from Pennsylvania State University have developed a synthetic microbiome therapy to fight potentially lethal Clostridioides difficile Infection (CDI). The therapy works similary to a fecal transplant but is more precise, identifying a Peptostreptococcus bacterial strain crucial for suppressing CDI. The research promises more focused and effective strategies to deal with CDI and potentially other conditions like inflammatory bowel disease.
Healthcare workforce being changed by AI and emerging technologies
The content outlines the enterprise taxonomy, which includes categories such as Operations, Analytics, AI, Digital Health, Workforce Development, Business, Data and Information Technology, and Workforce.
